Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Dale Terasaki to Humans

This is a "connection" page, showing publications Dale Terasaki has written about Humans.

 
Connection Strength
 
 
 
0.257
 
  1. Lyden J, Loh R, Braun H, Terasaki D. Characterizing safer drinking strategies among hospitalized adults with severe alcohol use disorder; a cross-sectional secondary analysis. J Addict Dis. 2024 Oct-Dec; 42(4):551-555.
    View in: PubMed
    Score: 0.025
  2. Terasaki D, Hanratty R, Thurstone C. More than MAT: lesser-known benefits of an inpatient addiction consult service. Hosp Pract (1995). 2023 08; 51(3):107-109.
    View in: PubMed
    Score: 0.024
  3. Deaney M, Terasaki D. Intramuscular, extended-release naltrexone inadvertently administered in the deltoid muscle: A case report. J Am Pharm Assoc (2003). 2023 Jul-Aug; 63(4):1245-1248.
    View in: PubMed
    Score: 0.024
  4. Terasaki D, Kulick B, Calcaterra S, Ray L. Phenobarbital for alcohol withdrawal in the context of the opioid epidemic: a neglected caveat. Addiction. 2023 07; 118(7):1198-1200.
    View in: PubMed
    Score: 0.024
  5. Terasaki D. Self-reported Past Experiences With Naltrexone and Attitudes Toward Daily Adherence Among High-utilization Patients With Alcohol Use Disorder. J Addict Med. 2023 May-Jun 01; 17(3):371-372.
    View in: PubMed
    Score: 0.024
  6. Terasaki D, Loh R, Cornell A, Taub J, Thurstone C. Single-dose intravenous ketamine or intramuscular naltrexone for high-utilization inpatients with alcohol use disorder: pilot trial feasibility and readmission rates. Addict Sci Clin Pract. 2022 11 22; 17(1):64.
    View in: PubMed
    Score: 0.023
  7. Terasaki D, Brady J. Severe, Nondelirium Agitation as an Underreported Characteristic of Precipitated Fentanyl Withdrawal: A Case Report. J Addict Med. 2023 Jan-Feb 01; 17(1):111-113.
    View in: PubMed
    Score: 0.023
  8. Terasaki D. Cardiovascular medications on discharge for patients with chest pain and concurrent cocaine use. Am J Emerg Med. 2022 08; 58:315-316.
    View in: PubMed
    Score: 0.022
  9. Terasaki D, Klie K. Tramadol Withdrawal in the Setting of Buprenorphine Induction: A Case Report. J Addict Med. 2020 May/Jun; 14(3):264-266.
    View in: PubMed
    Score: 0.020
  10. Terasaki D, Smith C, Calcaterra SL. Transitioning Hospitalized Patients with Opioid Use Disorder from Methadone to Buprenorphine without a Period of Opioid Abstinence Using a Microdosing Protocol. Pharmacotherapy. 2019 10; 39(10):1023-1029.
    View in: PubMed
    Score: 0.019
  11. Terasaki D, Ornelas I, Saelens B. Length of Residence and Vehicle Ownership in Relation to Physical Activity Among U.S. Immigrants. J Immigr Minor Health. 2017 04; 19(2):484-488.
    View in: PubMed
    Score: 0.016
  12. Terasaki DJ, Gelaye B, Berhane Y, Williams MA. Anger expression, violent behavior, and symptoms of depression among male college students in Ethiopia. BMC Public Health. 2009 Jan 12; 9:13.
    View in: PubMed
    Score: 0.009
  13. Mortaji P, Terasaki D, Moo-Young J. Advanced Inpatient Management of Opioid Use Disorder in a Patient Requiring Serial Surgeries. J Gen Intern Med. 2021 08; 36(8):2448-2451.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2024 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)